- Published at
- by globenewswire.com
mixed
mixed
News for OncoTherapy Science, Inc. (4564.T)
- Published at
- by globenewswire.com
mixedmixedBreast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The rising global incidence of breast cancer, driven by lifestyle changes and an aging population, is a key market driver. Technological advancements in...- Published at
- by globenewswire.com
mixedmixedMetastatic Breast Cancer Pipeline Report: Emerging Therapies and Treatment Outlook | DelveInsight
Metastatic Breast Cancer Pipeline involves 120+ key companies continuously working towards developing 120+ Metastatic Breast Cancer treatment therapies, as...- Published at
- by globenewswire.com
mixedmixedHER2 negative Breast Cancer Pipeline Insights | Research Report 2022 by DelveInsight
HER2 negative Breast Cancer Pipeline involves 85+ key companies continuously working towards developing 85+ HER2 negative Breast Cancer treatment...- Published at
- by marketscreener.com
negativenegativeShionogi : About a Phase III Clinical Study of Cancer-Specific Peptide Vaccine S-588410 in Patients with Esophageal Cancer
Press Release About a Phase III Clinical Study of Cancer-Specific Peptide Vaccine S-588410 in Patients with Esophageal Cancer ... | July 16, 2021